van Hout BA - Search Results

1

Association between joint bleeds and Pettersson scores in severe haemophilia.

Fischer K, van Hout BA, van der Bom JG, Grobbee DE, van den Berg HM. Fischer K, et al. Among authors: van den berg hm, van der bom jg, van hout ba. Acta Radiol. 2002 Sep;43(5):528-32. Acta Radiol. 2002. PMID: 12423465

2

A modeling approach to evaluate long-term outcome of prophylactic and on demand treatment strategies for severe hemophilia A.

Fischer K, Pouw ME, Lewandowski D, Janssen MP, van den Berg HM, van Hout BA. Fischer K, et al. Among authors: van den berg hm, van hout ba. Haematologica. 2011 May;96(5):738-43. doi: 10.3324/haematol.2010.029868. Epub 2011 Jan 27. Haematologica. 2011. PMID: 21273268 Free PMC article.

3

Clinical effectiveness of influenza vaccination in persons younger than 65 years with high-risk medical conditions: the PRISMA study.

Hak E, Buskens E, van Essen GA, de Bakker DH, Grobbee DE, Tacken MA, van Hout BA, Verheij TJ. Hak E, et al. Among authors: van essen ga, van hout ba. Arch Intern Med. 2005 Feb 14;165(3):274-80. doi: 10.1001/archinte.165.3.274. Arch Intern Med. 2005. PMID: 15710789

4

Design of the Dutch prevention of influenza, surveillance and management (PRISMA) study.

Hak E, van Loon S, Buskens E, van Essen GA, de Bakker D, Tacken MA, van Hout BA, Grobbee DE, Verheij TJ. Hak E, et al. Among authors: van essen ga, van loon s, van hout ba. Vaccine. 2003 Apr 2;21(15):1719-24. doi: 10.1016/s0264-410x(02)00520-0. Vaccine. 2003. PMID: 12639495

5

Recommendations for reporting economic evaluations of haemophilia prophylaxis: a nominal groups consensus statement on behalf of the Economics Expert Working Group of The International Prophylaxis Study Group.

Nicholson A, Berger K, Bohn R, Carcao M, Fischer K, Gringeri A, Hoots K, Mantovani L, Schramm W, van Hout BA, Willan AR, Feldman BM. Nicholson A, et al. Among authors: van hout ba. Haemophilia. 2008 Jan;14(1):127-32. doi: 10.1111/j.1365-2516.2007.01562.x. Epub 2007 Nov 13. Haemophilia. 2008. PMID: 18005148

6

Prevention comes of age?

Bonneux LG, van Hout BA, van Delden JJ, Grobbee DE. Bonneux LG, et al. Among authors: van delden jj, van hout ba. Eur J Epidemiol. 2003;18(12):1107-8. doi: 10.1023/b:ejep.0000006613.92910.7b. Eur J Epidemiol. 2003. PMID: 14758865 No abstract available.

7

Efficacy of recombinant activated factor VII vs. activated prothrombin complex concentrate for patients suffering from haemophilia complicated with inhibitors: a Bayesian meta-regression.

Treur MJ, McCracken F, Heeg B, Joshi AV, Botteman MF, De Charro F, Van Hout B. Treur MJ, et al. Haemophilia. 2009 Mar;15(2):420-36. doi: 10.1111/j.1365-2516.2008.01956.x. Haemophilia. 2009. PMID: 19335751 Review.

8

A probabilistic model for analyzing viral risks of plasma-derived medicinal products.

Janssen MP, Over J, van der Poel CL, Cuijpers HT, van Hout BA. Janssen MP, et al. Among authors: van der poel cl, van hout ba. Transfusion. 2008 Jan;48(1):153-62. doi: 10.1111/j.1537-2995.2007.01493.x. Epub 2007 Sep 24. Transfusion. 2008. PMID: 17894786

9

Monitoring viral incidence rates: tools for the implementation of European Union regulations.

Janssen MP, Cator EA, van der Poel CL, Schaasberg WP, Bonsel GJ, van Hout BA. Janssen MP, et al. Among authors: van der poel cl, van hout ba. Vox Sang. 2009 May;96(4):298-308. doi: 10.1111/j.1423-0410.2009.01166.x. Epub 2009 Feb 18. Vox Sang. 2009. PMID: 19228368

10

Modelling approaches: the case of schizophrenia.

Heeg BM, Damen J, Buskens E, Caleo S, de Charro F, van Hout BA. Heeg BM, et al. Among authors: van hout ba. Pharmacoeconomics. 2008;26(8):633-48. doi: 10.2165/00019053-200826080-00002. Pharmacoeconomics. 2008. PMID: 18620458

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

151 results

Search Page

Filters